Elaine Del Bel
Has grant
Professor
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Recent Grants
Grant: Close
Contribution of the neuroinflamation to L-DOPA induced dyskinesia
Open Date: 2016-04-01
Close Date: 2019-03-31
Grant: Close
Analysis of nitric oxide synthase in dopaminergic and non dopaminergic neurons in experimental Parkinson Disease: role of NOS inhibitors in L-DOPA induced diskinesias
Open Date: 2009-01-01
Close Date: 2013-03-31
Grant: Close
Complementação da estruturação para autonomia de consórcio de laboratórios do Departamento de Morfologia Estomatologia e Fisiologia da Faculdade de Odontologia de Ribeirão Preto da Universidade de São Paulo
Open Date: 2005-09-01
Close Date: 2008-05-31
Grant: Close
Análise da recuperação neural após lesão
Open Date: 2001-05-01
Close Date: 2003-07-31
Grant: Close
Plasticidade neuronal em resposta a estressores: alterações moleculares e comportamentais
Open Date: 1996-08-01
Close Date: 2000-09-30
Articles (13)
Year:
2024
Year:
2024
Year:
2024
To study the anti‐inflammatory potential of the two synthetic cannabinoids 4′‐F‐CBD and HU‐910, we used post‐natal brain cultures of mouse microglial cells and astrocytes activated by reference inflammogens. We found that 4′‐F‐CBD and HU‐910 efficiently curtailed the release of TNF‐α, IL‐6, and IL‐1β in microglia and astrocytes activated by the bacterial Toll‐Like Receptor (TLR)4 ligand LPS. Upon LPS challenge, 4′‐F‐CBD and HU‐910 also prevented the activation of phenotypic activation markers specific to microglia and astrocytes, that is, Iba‐1 and GFAP, respectively. In microglial cells, the two test compounds also efficiently restrained LPS‐stimulated release of glutamate, a non‐cytokine inflammation marker for these cells. The immunosuppressive effects of the two cannabinoid compounds were concentration‐dependent and observable between 1 and 10 μM. These effects were not dependent on cannabinoid or cannabinoid‐like receptors. Both 4′‐F‐CBD and HU‐910 were also capable of restraining the inflammogenic activity of Pam3CSK4, a lipopeptide that activates TLR2, and of BzATP, a prototypic agonist of P2X7 purinergic receptors, suggesting that these two cannabinoids could exert immunosuppressive effects against a variety of inflammatory stimuli. Using LPS‐stimulated microglia and astrocytes, we established that the immunosuppressive action of 4′‐F‐CBD and HU‐910 resulted from the inhibition of ROS produced by NADPH oxidase and subsequent repression of NF‐κB‐dependent signaling events. Our results suggest that 4′‐F‐CBD and HU‐910 may have therapeutic utility in pathological conditions where neuroinflammatory processes are prominent.
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Collaborators (12)
Alexander Birbrair
Tenure-track Assistant Professor
University of Wisconsin-Madison
Samia Joca
VIP, Associate Professor
Aarhus University
Jean Michel Brunel
Aix-Marseille University
Ana González-Cuello
Senior Lecturer
Universidad de Murcia
Pilar Almela
Associate Professor
Universidad de Murcia
María-Trinidad Herrero
Directora de la Cátedra de Comunicación Sanitaria
Universidad de Murcia
Maurício dos-Santos-Pereira
Assistant Professor
University of Sao Paulo
Nicole Rodrigues
Assistant Professor
Aarhus University
Glauce Crivelaro Nascimento
Professor
University of Sao Paulo
Rita Raisman-Vozari
Directeur de Recherche
CNRS Délégation Paris B
Pedro Gobira
Assistant Professor
Aarhus University
Patrick Pierre Michel
Senior PI
Institut du Cerveau et de la Moelle Épinière
Make your next move.
Prepare your application
Review drafts before you send them.